Inorevia is a French startup exploiting cutting-edge patented technologies to accelerate Research in Biology and Medicine. By providing researchers and clinicians with innovative tools, Inorevia aims at solving the challenge of increasing complexity in Biology.
At the core of Inorevia’s products lie patented technologies harnessing the power of microfluidics to miniaturize and automate hundreds of Biology protocols, with unprecedented results.
Inorevia’s robust, intuitive and fully automated instruments will pave the way toward a new generation of solutions for Life Sciences.
Inorevia's technology stems from 15 years
of research led at the Institute Curie (UMR168, CNRS).
Inorevia continues to receive strong national and regional support, particularly from the Ile de France region, and EIC Accelerator from Europe.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 873262